5901 related articles for article (PubMed ID: 23387001)
1. Decreased melanoma proliferation and cell survival: turn down your SOX10.
Loftus SK
Pigment Cell Melanoma Res; 2013 Jan; 26(1):3-4. PubMed ID: 23387001
[No Abstract] [Full Text] [Related]
2. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
3. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
4. UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling.
Dikshit A; Jin YJ; Degan S; Hwang J; Foster MW; Li CY; Zhang JY
Cancer Res; 2018 Nov; 78(22):6462-6472. PubMed ID: 30224375
[TBL] [Abstract][Full Text] [Related]
5. A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms.
Jackson CR; Sriharan A; Vaickus LJ
Mod Pathol; 2020 Sep; 33(9):1638-1648. PubMed ID: 32238879
[TBL] [Abstract][Full Text] [Related]
6. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characterization of mouse models of melanoma.
Ferguson B; Soyer HP; Walker GJ
Methods Mol Biol; 2015; 1267():251-61. PubMed ID: 25636472
[TBL] [Abstract][Full Text] [Related]
8. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.
Rosenbaum SR; Tiago M; Caksa S; Capparelli C; Purwin TJ; Kumar G; Glasheen M; Pomante D; Kotas D; Chervoneva I; Aplin AE
Cell Rep; 2021 Dec; 37(10):110085. PubMed ID: 34879275
[TBL] [Abstract][Full Text] [Related]
9. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
Silva CY; Goldberg LJ; Mahalingam M; Bhawan J; Wolpowitz D
J Cutan Pathol; 2011 Oct; 38(10):797-800. PubMed ID: 21812802
[TBL] [Abstract][Full Text] [Related]
10. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
[TBL] [Abstract][Full Text] [Related]
11. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
12. SOX2 modulates levels of MITF in normal human melanocytes, and melanoma lines in vitro.
Cimadamore F; Shah M; Amador-Arjona A; Navarro-Peran E; Chen C; Huang CT; Terskikh AV
Pigment Cell Melanoma Res; 2012 Jul; 25(4):533-6. PubMed ID: 22571403
[No Abstract] [Full Text] [Related]
13. A rare case of invasive melanoma likely arising from passenger melanocytes of a basal cell carcinoma.
Paladichuk H; Talbott LB
J Cutan Pathol; 2020 Dec; 47(12):1192-1195. PubMed ID: 32716592
[TBL] [Abstract][Full Text] [Related]
14. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
15. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
16. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
17. Detection of Occult Invasion in Melanoma In Situ.
Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
[TBL] [Abstract][Full Text] [Related]
18. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
[TBL] [Abstract][Full Text] [Related]
19. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
20. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
